KRAS Gene Mutation in Patients with Primary Colorectal Cancer
Objective: KRAS mutation occurs in 30% to 50% of colorectal cancers. The aim of our study was to determine the frequency of KRAS mutations among patients with colorectal cancer; and the relationship with clinicopathologic features. Materials and Methods: 79 colorectal cancer cases at a hospital in Hai Phong of Vietnam were collected, including 45 colon cancer and 34 rectal cancer during January 2010 and July 2012. PCR amplification and DNA sequencing were used to detect mutations in exon 2 of KRAS gene. The study was based on informed con- sent and approval by the Ethics Committee of Viet Tiep Hospital. Results: KRAS mutation was found in 40.4% (225/557) colorectal cancer. All mu- tation locations were in codon 12. There was significant association (p < 0.05) be- tween KRAS mutations and tumor size, tumor stage or metastatic stage. No signif- icant association was observed between KRAS mutations and gender, tumor loca- tion, tumor grade or histologic presence of mucin (p>0.05). Conclusion: Determining the KRAS mutational status of tumor samples has be- come an essential tool for managing patients with colorectal cancers.
___
Brink M, de Goeij AF, Weijenberg MP, et al. K-ras oncogene mu- tations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis 2003; 24: 703-10.Anh PH. Cancer in Ha Noi. Vietnam Medical Journal 1993; 7: 14-21.
Souglakos J. Genetic alterations in sporadic and hereditary colorectal cancer: implementations for screening and follow-up. Dig Dis 2007; 25: 9-19.
Jackson EL, Willis N, Mercer K, et al. Analysis of lung tumor initia- tion and progression using conditional expression of oncogenic K-ras. Genes Dev 2001; 15: 3243-8.
Tan C and Du X. KRAS mutation testing in metastatic colorectal cancer. World J Gastroenterol 2012; 18: 5171-80.
Fu X, Huang Y, Fan X, et al. Demographic Trends and KRAS/ BRAF(V600E) Mutations in Colorectal Cancer Patients of South China: a Single-site Report. Int J Cancer 2019; 144: 2109-17.
Guo F, Gong H, Zhao H, et al. Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients. Sci Rep 2018; 8: 6076.
Hamzehzadeh L, Khadangi F, Ghayoor Karimiani E, et al. Common KRAS and NRAS gene mutations in sporadic colorectal cancer in Northeastern Iranian patients. Curr Probl Cancer 2018; 42: 572-81.
Inoue Y, Saigusa S, Iwata T, et al. The prognostic value of KRAS mutations in patients with colorectal cancer. Oncol Rep 2012; 28: 1579-84.
Dinu D, Dobre M, Panaitescu E, et al. Prognostic significance of KRAS gene mutations in colorectal cancer--preliminary study. J Med Life 2014; 7: 581-87.
Ciardiello F, Tejpar S, Normanno N, et al. Uptake of KRAS mutation testing in patients with metastatic colorectal cancer in Europe, Latin America and Asia. Target Oncol 2011; 6: 133-45.
Li FH, Shen L, Li ZH, et al. Impact of KRAS mutation and PTEN expression on cetuximab-treated colorectal cancer. World J Gastroenterol 2010; 16: 5881-88.
Breivik J, Meling GI, Spurkland A, et al. K-ras mutation in colorec- tal cancer: relations to patient age, sex and tumour location. Br J Cancer 1994; 69: 367-71.
Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 2008; 359: 1757-65.
Beranek M, Bures J, Palicka V, et al. A relationship between K-ras gene mutations and some clinical and histologic variables in pa- tients with primary colorectal carcinoma. Clin Chem Lab Med 1999; 37: 723-27.
Monstein HJ, Fransen K, Dimberg J, et al. K-ras and B-raf gene mutations are not associated with gastrin- and CCK2-receptor mRNA expression in human colorectal tumour tissues. Eur J Clin Invest 2004; 34: 100-06.
Zulhabri O, Rahman J, Ismail S, et al. Predominance of G to A codon 12 mutation K-ras gene in Dukes’ B colorectal cancer. Singapore Med J 2012; 53: 26-31.
[Chang YS, Yeh KT, Chang TJ, et al. Fast simultaneous detection of K-RAS mutations in colorectal cancer. BMC Cancer 2009; 9: 179
- ISSN: 2147-9488
- Yayın Aralığı: Yılda 4 Sayı
- Başlangıç: 2012
- Yayıncı: HACETTEPE ÜNİVERSİTESİ
Sayıdaki Diğer Makaleler
AHMET ÇAĞKAN İNKAYA, Emel TÜRK ARIBAŞ, İbrahim ERAYMAN, BAHAR KANDEMİR, Hasan ACAR, Mehmet BİTİRGEN
Phrenic Nerve Damage After Atrial Fibrillation Ablation Using Second Generation Cryoballoon
HİKMET YORGUN, Yusuf Ziya ŞENER, Metin OKŞUL, UĞUR CANPOLAT, Banu EVRENOS, AHMET HAKAN ATEŞ, KUDRET AYTEMİR
Aysun ŞAHİN, AYSUN ANKAY YILBAŞ, A. Gülsün PAMUK, BAŞAK AKÇA, FİLİZ ÜZÜMCÜGİL, NALAN ÇELEBİ
Skipping Breakfast Everyday Keeps Well-being Away
Extra-Spinal Tuberculosis Arthritis: Case Report
KRAS Gene Mutation in Patients with Primary Colorectal Cancer
Vu Thi Minh THUC, Le Van THIEU, Huynh Quang HUY, Nguyen Minh DUC